Company Registration 14 September 2026
Gland Pharma fined ₹1.40 lakh for director norm breach
India’s Gland Pharma has been levied a ₹1.40 lakh penalty for a technical breach of director appointment norms. The company filed the required intimation with both BSE and NSE, and the compliance notice was signed by Company Secretary Sampath Kumar Pallerlamudi, highlighting regulatory oversight failures.
Gland Pharma has been penalised ₹1.40 lakh for not adhering to director appointment rules. The fine was imposed after the firm filed the necessary intimation with India’s stock exchanges.
- Penalty amount: ₹1.40 lakh
- Breach: Technical violation of director norms
- Exchanges notified: BSE and NSE
- Compliance officer: Sampath Kumar Pallerlamudi, Company Secretary & Compliance
For full details, see the original report on ScanX: Gland Pharma pays ₹1.40 lakh fine for technical breach of director norms.
Need help understanding this update?
Connect with our domain experts instantly via WhatsApp for customized legal guidance.